Isabelle Rivière

Isabelle Rivière, PhD, is a Scientific Advisor at Mnemo. In addition to her role at Mnemo, she also serves on the Advisory Board of the Center for Commercialization of Cancer Immunotherapy C3i (Canada) and the National Science Foundation (NSF) Engineering Research Center (ERC) for Cell Manufacturing Technologies (CMaT). Isabelle brings over 20 years of extensive clinical expertise in cell therapy and molecular biology research. In 1999, Isabelle joined the faculty of Memorial Sloan-Kettering Cancer Center where she focuses on developing novel strategies for cell therapies and immunotherapies. Her laboratory investigates genetic approaches to enhance various cell types including T lymphocytes and stem cells for the treatment of cancer and genetic blood disorders. Over the past 20 years, she has conceived and implemented multiple cell manufacturing processes for several Phase I/II clinical trials. Her lab currently supports multiple CAR T cell-based clinical trials for the treatment of hematological malignancies and solid tumors. She also investigates immunological functions of CAR T cells in clinical trials and animal models. She previously served as a member of the Board of Directors of the American Society of Gene and Cell Therapy (ASGCT) and of the Alliance for Regenerative Medicine (ARM). Isabelle received her PhD in Cell Therapy and Molecular Biology from the University of Paris.